Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nephrogenic diabetes insipidus.

Daniel G Bichet1

  • 1Centre de Recherche, Hôpital du Sacré-Couer de Montréal, Montreal, Quebec, Canada. Daniel.bichet@umontreal.ca

Advances in Chronic Kidney Disease
|April 4, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GLUT9b- and ABCG2-mediated collecting duct urate transport uncover a vasopressin-independent mechanism of renal water reabsorption.

The Journal of clinical investigation·2026
Same author

Canadian Society of Nephrology Commentary on the 2025 Kidney Disease Improving Global Outcomes Clinical Practice Guidelines for Autosomal Dominant Polycystic Kidney Disease.

Canadian journal of kidney health and disease·2026
Same author

Association of Kidney Volume With Patient-Reported Outcomes in ADPKD.

Kidney international reports·2026
Same author

Eight Years of Canadian Real-World Assessment of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease: The C-MAJOR Registry.

Canadian journal of kidney health and disease·2026
Same author

Thirsty encounters of the third kind.

Kidney international·2025
Same author

International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance).

Nature reviews. Nephrology·2024
Same journal

The Physician Leader: Teaching Leadership in Medicine.

Advances in chronic kidney disease·2022
Same journal

Postgraduate Education and Training for the Nephrology Physician Assistants and Nurse Practitioners.

Advances in chronic kidney disease·2022
Same journal

Evaluation Evolution: Designing Optimal Evaluations to Enhance Learning in Nephrology Fellowship.

Advances in chronic kidney disease·2022
Same journal

Kidney Pathology Education for Nephrology Fellows: Past, Present, and Future.

Advances in chronic kidney disease·2022
Same journal

Clinician Educator Pathway for Nephrology Fellows: The University of North Carolina Experience.

Advances in chronic kidney disease·2022
Same journal

Current Trends and Challenges in Nephrology Fellowship Training: Expansion of Education in Home Dialysis, Palliative Care, and Point-of-Care Ultrasound.

Advances in chronic kidney disease·2022
See all related articles

Nephrogenic diabetes insipidus (NDI) results from genetic mutations affecting the arginine-vasopressin receptor 2 (AVPR2) or aquaporin-2 (AQP2) genes. Early diagnosis through genetic testing is crucial to prevent developmental delays caused by dehydration.

Area of Science:

  • Nephrology
  • Medical Genetics
  • Molecular Biology

Background:

  • Nephrogenic diabetes insipidus (NDI) is a condition characterized by the inability to concentrate urine, despite normal or high levels of arginine vasopressin (AVP).
  • Cardinal symptoms include polyuria, hyposthenuria, and polydipsia.
  • Congenital NDI is predominantly X-linked recessive, caused by mutations in the AVPR2 gene, while a smaller proportion results from autosomal mutations in the AQP2 gene.

Purpose of the Study:

  • To review the genetic basis of NDI, focusing on mutations in the AVPR2 and AQP2 genes.
  • To highlight the clinical significance of identifying these mutations for early diagnosis and management.

Main Methods:

  • Review of existing literature on NDI genetics.
  • Analysis of mutation types in AVPR2 and AQP2 genes and their functional consequences.

Related Experiment Videos

  • Discussion of diagnostic and clinical implications.

    • Main Results:

    • Approximately 90% of congenital NDI cases involve mutations in the AVPR2 gene, leading to defective vasopressin V2 receptors.
    • About 10% of congenital NDI cases are linked to mutations in the AQP2 gene, affecting the vasopressin-sensitive water channel.
    • Most identified mutations result in misrouted receptor or channel proteins, impairing cellular function.

    Conclusions:

    • Mutations in AVPR2 and AQP2 are the primary causes of inherited NDI.
    • Understanding these genetic defects is vital for early diagnosis and intervention.
    • Perinatal genetic testing can prevent severe complications like dehydration-induced physical and mental retardation.